Predicting muscle loss during lung cancer treatment (PREDICT): protocol for a mixed methods prospective study.

Nicole K KissLinda DenehyLara EdbrookeCarla M PradoDavid BallShankar SivaGavin AbbottAnna UgaldeSteve F FraserSarah EverittNicholas HardcastleAndrew WirthRobin M Daly

Published in: BMJ open (2021)

The PREDICT study received ethics approval from the Human Research Ethics Committee at Peter MacCallum Cancer Centre (HREC/53147/PMCC-2019) and Deakin University (2019-320). Findings will be disseminated through peer review publications and conference presentations.

Keyphrases

public health
endothelial cells
big data
papillary thyroid
randomized controlled trial
skeletal muscle
induced pluripotent stem cells
squamous cell carcinoma
clinical trial
lymph node metastasis
deep learning
childhood cancer